← Back to Patent Explorer
US3963025A Expired / Lapsed US ⏱️ 0.0 years remaining

Ocular drug delivery device

Assignee: Alza Corp
•
Filing: 1975-06-02
•
Granted: 1976-06-15
•
Expires: 1995-06-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Ocular drug delivery device comprising a bioerodible body of polymeric material sized and shaped for insertion in either conjunctival cul-de-sac that have improved retention in the eye. The devices have a stiffness and resistivity to bending manifested by a centroidal unsupported bending angle of less than 40°, preferably less than 20°, during the drug dispensing lifetime of the device.

Inventors

  • 👤 Gordon W. Whitaker
  • 👤 Yigal Gad

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 10:14
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0048; A61K9/0051; A61F; A61F9/00; A61F9/0008; A61F9/0017

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 63 words
In a sustained release ocular drug delivery device comprising a flexible body that is formed of a bioerodible polymeric material, sized and shaped for insertion in either cul-de-sac of the eye, and contains a drug, the improvement wherein the body has a stiffness and resistivity to bending manifested by a centroidal unsupported bending angle of less than 40° during its drug dispensing lifetime.
Claim 2
Dependent Claim 63 words
In a sustained release ocular drug delivery device comprising a flexible body that is formed of a bioerodible polymeric material, sized and shaped for insertion in either cul-de-sac of the eye, and contains a drug, the improvement wherein the body has a stiffness and resistivity to bending manifested by a centroidal unsupported bending angle of less than 40° during its drug dispensing lifetime.
Claim 3
Dependent Claim 20 words
The improvement of claim 1 wherein the centroidal unsupported bending angle is less than 20° during said drug dispensing lifetime.
Claim 4
Dependent Claim 12 words
The improvement of claim 1 wherein said polymeric material is cross-linked gelatin.
Claim 5
Dependent Claim 28 words
The improvement of claim 1 wherein said body is 3 - 20 mm in length, 1 - 9 mm in width and 0.05 - 1 mm in thickness.
Claim 6
Dependent Claim 16 words
The improvement of claim 1 wherein the drug dispensing lifetime is in excess of one-half day.
Claim 7
Dependent Claim 15 words
The improvement of claim 1 wherein the drug dispensing lifetime is at least one day.
Claim 8
Dependent Claim 38 words
The improvement of claim 1 wherein the body is 3 - 20 mm in length, 1 - 9 mm in width and 0.05 - 1 mm in thickness and the drug dispensing lifetime is at least one day.
Claim 9
Dependent Claim 12 words
The improvement of claim 7 wherein the polymeric material is cross-linked gelatin.

References Cited (Backward Citations)

US3626940A Cited
US3630200A Cited
US3828777A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-06-15 1979-12-15 1980-06-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-06-15 1983-12-15 1984-06-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-06-15 1987-12-15 1988-06-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag